Market Research

  According to MRFR analysis , Hip Implants Market  is expected to register a CAGR of 4.1 %  during the forecast period and is expected to reach USD 9,300 Million by 2025. Hip replacement is a surgical procedure in which the hip joint is replaced by a prosthetic implant, which is also known as hip prosthesis.  Hip replacement surgery can be performed as a hemi (half) replacement or total replacement. The growth of the global hip implants market is driven by various factors, such as the introduction of custom-made implants and the growing geriatric population. Increased product launches, mergers, acquisitions, and partnerships of the major players of the market attributed to the growth of the market. However, stringent government regulations on all-metal hip implants and an increase in the number of product recalls are projected to hamper the growth of the global hip implants market. Several market players currently dominat...

According to MRFR analysis,  Vitiligo Treatment Market  is expected to register a CAGR of 5.6% during the forecast period was valued at USD 1.22 Billion in 2018. Vitiligo is a skin disorder that causes white patches to appear on the skin. These patches occur because the melanocytes are destroyed, leaving areas of skin with no pigment at all. It can affect any skin part of the body. The growth of the global vitiligo treatment market is driven by various factors such as emerging therapies for skin disorders, increasing healthcare expenditure, lifestyle changes. However, the lack of skilled professionals is expected to curb the growth of the global vitiligo treatment market. Several market players currently dominate the global vitiligo treatment market. The key players are involved in product launches and strategic collaborations to strengthen their market positions. For instance, Incyte Corporation reported positive results from the study of ruxolitinib cream which is in phase 2...

  According to MRFR analysis, the global  liver cirrhosis treatment market  is expected to register a CAGR of ~5.2% during the forecast period and was valued at USD 956.89 million in 2018. The growth of the global liver cirrhosis treatment market is driven by various factors such as an increasing global geriatric population, rising prevalence of liver cirrhosis, rapidly changing lifestyle, growing awareness programs regarding liver diseases, rising R&D investment for the development of innovative drugs for liver diseases, and increasing demand for better treatment methods for curing liver cirrhosis. However, stringent government regulations, high investment required for drug research & development, and side-effects of medications prescribed for liver cirrhosis are the factors that are expected to limit the growth of the global liver cirrhosis treatment market. Liver cirrhosis is basically the late-stage scarring of the liver caused due to various types of live...

  The Global Onychomycosis Market is expected to register a CAGR of 6.28% during the forecast period with a market value of USD 7,912.5 Million till 2025. Onychomycosis is a general term used to denote any fungal nail infection. Factors such as the surging diabetic patient population, rising per capita healthcare expenditure coupled with the rising occurrences of onychomycosis, are anticipated to fuel the growth of the global onychomycosis market. However, the lack of awareness about onychomycosis and the side-effects associated with onychomycosis treatment drugs is likely to hamper the market growth. Segment Analysis The global onychomycosis market, by type, has been divided into distal subungual onychomycosis (DSO), white superficial onychomycosis (WSO) , proximal subungual onychomycosis (PSO), candida onychomycosis, and others. On the basis of treatment type, the global onychomycosis market has been divided into drug treatment, topical therapy, and others. The glo...

The Global   Cardiomyopathy Medication Market   is anticipated to reach USD 620 Million by 2025 at a CAGR of ~4.60% during the forecast period. Cardiomyopathy is a disease that causes the thickening and enlargement of the heart muscles and abnormal blood flow. Patients suffering from cardiomyopathy showcase symptoms such as dizziness, coughing, fatigue, and swelling of the legs, ankles, and feet. Certain factors that propel the growth of the global cardiomyopathy medication market are the high patient pool of heart disease, focus on manufacturing medication for cardiomyopathy treatment, and rising healthcare expenditure.  Currently, the global cardiomyopathy medication market is dominated by several players. The major players in this market are involved in strategic acquisitions and product launches to expand their product portfolios. For instance, in May 2019, Pfizer Inc. received US FDA approval for Vyndamax (tafamidis) and Vyndaqel (tafamidis meglumine) for the treatme...

According to MRFR analysis, the global  implantable cardioverter defibrillator (ICD) market  is expected to register a CAGR of 5.96% during the forecast period. Implantable Cardioverter Defibrillator (ICD) is used to record the heart's activity and treat dangerous ventricular arrhythmias with an electrical shock or pulse to the heart. Factors such as the growing aging population, changing lifestyles such as smoking and alcohol consumption, and the increase in demand for cardiac implants are responsible for the increasing prevalence of cardiac arrhythmias globally. This is likely to fuel the growth of the ICD market during the forecast period. In addition to this, improving efficacy of ICDs for the treatment of cardiac diseases over a period will also fuel the market. According to the American Heart Association, approximately 1.5 million cases of myocardial infarction occur annually, and the incidence rate is approximately 600 cases per 100,000 people in the US. According to th...

The global  telehealth market  is growing pervasively mainly due to the range of advantages the telehealth it offers. Main five benefits of telehealth include improved outcomes, enhanced care-coordination that maximizes clinical efficiency driving consumer engagement, and all this at much-reduced costs. The uptake of Telehealth is on the rise as more users view telehealth as a viable alternative to traditional, in-person visits. As patients’ acceptance increases, the telehealth market will be evaluated in terms of value. Acknowledging the potential of the market to increase further, Market Research Future (MRFR) in its recently published study report asserts that the global telehealth market will perceive a splendid growth by 2023 registering a double-digit CAGR of 29.8% during the forecast. The patients' journey is unlikely to change since users of  telehealth services  will need to be seamlessly integrated into the familiar payer/provider constructs (access, reimbu...

According to MRFR analysis, the global  musculoskeletal system disorders market  is expected to register a CAGR of ~5.30% during the forecast period and was valued at USD 3837.7 million in 2018. Musculoskeletal system disorders affect movement or musculoskeletal systems such as muscles, tendons, and ligaments. These disorders are also known as repetitive motion injuries. Musculoskeletal system disorders can arise by making the same motion repeatedly or lifting heavy objects. They affect different parts of the body, mainly the upper and lower back and neck. The growth of global musculoskeletal system disorders market is driven by various factors such as an increasing global geriatric population, rising prevalence, and improper posture, and poor fitness levels. However, the high costs of surgery are expected to curb the growth of the global musculoskeletal system disorders market. The global musculoskeletal system disorders market is currently dominated by several market players...

The Global  Hazmat Suits Market  is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 6768.19 million in 2018 and is projected to register a CAGR of 5.9% over the forecast period. Hazmat suits are also known as chemical suits, biohazard suits, and anti-radiation suits. They are personal protective equipment which provides protection against chemical and biological hazards. The rising cases of Ebola are one of the key factors driving the hazmat suits market. In August 2018, as per data by Médecins Sans Frontières, Democratic Republic of Congo (DRC) faced by far the country's largest-ever Ebola outbreak with the number of cases passing 2,700. It is also the second-biggest Ebola epidemic ever recorded, behind the West Africa outbreak of 2014–2016. Various other factors such as the rising number of nuclear power plants across the globe and increased work safety are also expected to propel the growth of the market. Ho...

The  dental CAD/CAM market  is expected to register a CAGR of 11.57% during the forecast period 2021-2027, to reach USD 2,561.31 million by 2027. MRFR recognizes the following companies as the key players in the global dental CAD/CAM market—Danaher (US), Hexagon (Sweden), PLANMECA OY (Finland), 3Shape (Denmark), Dental Wings (Canada), Zimmer Biomet (US), Roland DGA Corporation (US), Dentsply Sirona (US), Align Technology Inc (US), Institute Straumann AG (Switzerland), and EG Solutions (England). Market Highlights The global dental CAD/CAM market is anticipated to reach a market value of USD 2,561.31 million by 2027. Dental computer-aided design and computer-aided manufacturing, or CAD/CAM, is the automation technology which provide support dental restoration. CAD/CAM supplements old technologies that were used for these dental resolutions by enhance the speed of design and manufacturing, increasing the correctness and comfort of the design, construction, and insertion procedur...

The global  anal fissure treatment market  is expected to rise and touch a valuation of USD 2,526.5 million at a 7.6% CAGR during the forecast period. Anal fissures are small tears near the mucosal lining of the anus. Deeper cuts may take a combination of oral and topical medicine to alleviate the pain. The anal fissure treatment market is expected to thrive owing to the booming pediatric and geriatric patient pool. Advances in technology coupled with various treatment options is likely to lead to a windfall for the market over the forecast period. High incidence of constipation is predicted to drive the need for anal fissure treatments. This is backed by vulnerability of the elderly which find it difficult to pass stools properly. According to the American Gastroenterological, nearly 33% of Americans above 60 experience the condition. Unhealthy lifestyles adopted by patients is likely to cause the condition and boost the market demand. Popularity of over the counter (OTC) dru...